Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-25 @ 8:20 PM
NCT ID:
NCT00543569
Group ID:
EG003
Title:
Alefacept QOW/Tacrolimus/MMF
Description:
Participants received alefacept administered as a 7.5 mg IV bolus on Days 0 and 3; 30 mg subcutaneously on Day 7 then weekly for 12 weeks, then 15 mg subcutaneously monthly until the end of month 6, in addition to tacrolimus at a starting dose of 0.10 mg/kg/day, MMF 750 or 1000 mg BID, and tapered corticosteroids for 6 months.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
45
Serious Number At Risk:
78
Other Number Affected:
78
Other Number At Risk:
78
Study:
NCT00543569
Results Section:
NCT00543569
Adverse Events Module:
NCT00543569